Table 1.
Overview of Epidemiologic Studies including Midlife Latinas
| Study | Country | Purpose | Study Years | Baseline Age (Years) | N | Latina % | Sex Hormones | VMS | Health Behaviors | Cardio-metabolic Factors | Psychological Factors and QOL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hilo Women’s Health Study | Hawaii, USA | To assess general health, menopause status, and health-related complaints among adult women in Hilo, Hawaii. | 2004–2005 | 40–60 | 994 | 0.9 | N/A | Yes | Diet/Nutrition; Physical activity; Smoking; Alcohol | BMI; Blood pressure; Hypertension; Diabetes; Cholesterol | N/A |
| San Francisco Midlife Women’s Health Study (SFMWHS) | San Francisco, CA, USA | To describe changes in the biopsychosocial health of midlife women through the menopausal transition. | 1996–2001 | 40–48 | 347 | 27.4 | Urine: FSH | Yes | Sleep quality | BMI | Social support; Stress; Discrimination |
| Seattle Midlife Women’s Health Study (SMWHS) | Seattle, WA, USA | To describe the menopause transition in terms of personal and social factors, hormone changes, stress, health behaviors, and symptoms in midlife women. | 1990–2013 | 35–55 | 508 | 1.2 | Urine: FSH, estrone, testosterone | Yes | Diet/Nutrition; Physical activity; Sleep quality; Alcohol | BMI; Hypertension; Diabetes; | Anxiety; Depression; Stress |
| Study of Women’s Health Across the Nation | Ann Arbor, MI; Boston, MA; Chicago, IL; Alameda and Contra Costa County, CA; Los Angeles, CA; Jersey City, NJ; and Pittsburgh, PA, USA | To examine the physical, biological, psychological and social changes of midlife women during the menopause transition. | 1996-Current | 42–52 | 3302 | 8.7 | Serum: FSH, estradiol, testosterone, SHBG | Yes | Diet/Nutrition; Physical activity; Smoking; Sleep quality; Alcohol; Illicit Drugs | BMI; Blood pressure; Hypertension; Diabetes; Lipids; Subclinical vascular measures; CVD | Anxiety; Childhood adversity; Depression; Social support; Stress; Discrimination; QOL |
| The Decision at Menopause Study (DAMES- USA) | MA, USA | To better understand the various factors that influence therapeutic decisions by middle-aged women related to the burden of menopause symptoms. | 2001–2002 | 45–55 | 293 | 1.00 | N/A | Yes | Physical activity; Smoking; Alcohol | BMI | N/A |
Note. FSH = follicle stimulating hormone, N/A = not applicable, QOL = quality of life, SHBG = sex hormone binding globulin, VMS = vasomotor symptoms